Our results showed that salidroside significantly down-regulated the expression of MAP3K6 and STAT3 genes in gastric cancer cells, indicating that salidroside suppressed the proliferation and progression of gastric cancer cells by inhibiting the expression of these pathway molecules. Here, STAT3 is linked to gastric cancer.